John Nicholas Staniforth,David Morton,Michael Tobyn,Stephen Eason,Quentin Harmer,David Granderton
申请号：
US13464445
公开号：
US20120321717A1
申请日:
2012.05.04
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to enhancing the dosing efficiency of pharmaceutical dry powder formulations administered by pulmonary inhalation. In particular, the present invention relates to the provision of dry powder inhalers and dry powder compositions which reproducibly achieve a much higher delivered dose of the pharmaceutically active agent than currently achieved.
